Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

June 8, 2020

Study Completion Date

June 8, 2020

Conditions
Alcohol Use DisorderHIV/AIDSHepatitis CBinge Drinking
Interventions
BEHAVIORAL

Intervention: (Clinician's Guide + HealthCall for HIV/HCV)

This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (\~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.

Trial Locations (1)

10032

NewYork-Presbyterian / Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT03652675 - Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV | Biotech Hunter | Biotech Hunter